AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06357754 — intervention group
Intervention type: BIOLOGICAL
Intervention: Lisocabtagene maraleucel
Description: As per product label
Study NCT06671717 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pralatrexate combined with Chidamide bridging Allogeneic Hematopoietic Stem Cell Transplantation
Description: Drug: Pralatrexate, Chidamide~1. Pralatrexate: 30 mg/m2 intravenously (IV) administered weekly in 6-week cycles. Chidamide: 20mg, twice a week in 3-week cycles (2 weeks on treatment, 1 week off treatment)~2. After the 6-week therapy, the patients should receive PET/CT evaluation.~3. Patients would receive allo-HSCT if they could achieve at least PR after the first cycle of therapy. For the patients could not achieve a least PR after the first cycle of therapy, they should receive a second cycle of pralatrexate combined with chidamide. The interval between two cycles of pralatrexate combined with chidamide should be at least 1 week.~4. After the second cycle of 6-week therapy, the patients should receive PET/CT evaluation. Patients would receive allo-HSCT if they could achieve at least SD after the second cycle of therapy. For the patients could not achieve a least SD after the second cycle of therapy, they should receive other salvage therapies.
Study NCT06673316 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Design thinking workshop
Description: The workshop will cover the five stages of design thinking, allowing students to apply these principles to real-world healthcare challenges in their future practice.
Study NCT05527717 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Culprit lesion only PCI
Description: Randomization will be done after coronary angiography before or during primary PCI for IRA. Patients will be randomized to either immediate multi-vesesl PCI group or culprit-lesion only PCI group with 1:1 ratio.~This group will be taken culprit-lesion only PCI during primary PCI.
Study NCT05527717 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate multi-vessel PCI
Description: Randomization will be done after coronary angiography before or during primary PCI for IRA. Patients will be randomized to either immediate multi-vesesl PCI group or culprit-lesion only PCI group with 1:1 ratio.~This group will be taken immediate multi-vesesl PCI during primary PCI.
Study NCT06676839 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: the complete ICOPE program
Description: The participant benefits from a personalized intervention, including 1) a screening to be repeated every 6 months, based on the use of the ICOPE tool, allowing an assessment of the 6 functions necessary for an autonomous lifestyle; 2) a comprehensive assessment step for the 6 functions 3) a personalized intervention step aimed at correcting the trajectory of functional decline, based on the participants' preferences; 4) a follow-up step for this intervention.~Participants will benefit from telephone follow-up 1.5 months after the start of the program and between each annual visit to support them in implementing their personalized intervention plan.~At each contact, the ICOPE nurse reviews the participant's implementation of the personalized intervention plan recommendations and their adherence to the program.~The results of the assessment and the proposed intervention are communicated and discussed with the primary care physician and a summary letter is also sent.
Study NCT06677424 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: NeuroCatch® Platform 2
Description: The NeuroCatch® Platform 2, a medical device system developed by NeuroCatch Inc., consists of software and hardware that captures brain health information. The platform intends to provide a quick, portable and easy to use solution for the acquisition, display, analysis, storage, reporting and management of electroencephalograph (EEG) and event-related potential (ERP; brain response to a stimulus) information. The device is approved as a medical device by Health Canada.
Study NCT06677385 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: diode laser as adjunctive to conventional scaling and debridement
Description: diode laser as adjunctive to conventional scaling and debridement for old age patients
Study NCT06677385 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional scaling and debridement
Description: conventional scaling and debridement
Study NCT06677255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VUM02 Injection (UC-MSCs)+BAT
Description: The dose-escalation phase (phase I):~Single dose escalation Phase 1a study: 3 dose levels of a single IV infusion; Multiple dose escalation Phase 1b study: 3 dose levels of twice weekly for 4 consecutive week.~The dose-expansion phase (phase II):~-Two dose groups will be selected by the investigator and the sponsor based on the results of the Phase 1b study, twice a week for 4 consecutive weeks for a total of 8 doses.
Study NCT06677255 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: The control group with Best Available Therapy (BAT)
Description: According to BAT scheme, the drug administration is determined by PI according to the condition of the patients.
Study NCT05832086 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasting Mimicking Diet (FMD)
Description: Consume the FMD (Xentigen, L-Nutra, Los Angeles, CA) for 5 days every monthly cycle for 6 cycles total in 6 months.
Study NCT05832086 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard Anti-Cancer Diet
Description: Will receive standard of care diet and exercise recommendations from the study dietitian. The diet advice will be consistent with the American Cancer Society for cancer survivors and exercise recommendation of a goal of 150 minutes/week of cardiovascular exercise and weight resistance training at least twice a week.
Study NCT05251207 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-carnitine
Description: L-carnitine-L-tartrate
Study NCT05251207 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: L-carnitine
Description: L-carnitine-L-tartrate
Study NCT05251207 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: L-leucine
Description: L-leucine
Study NCT06013059 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: three levels of TMJ arthroscopy
Description: Group I: 10 patients will be treated with Lysis and lavage
Study NCT06013059 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: three levels of TMJ arthroscopy
Description: Group II: 10 patients will be treated with operative arthroscopy
Study NCT06013059 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: three levels of TMJ arthroscopy
Description: Group III: 10 patients will be treated with operative arthroscopy + discopexy
Study NCT05251207 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-leucine
Description: L-leucine
Study NCT05251207 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: L-leucine
Description: L-leucine
Study NCT05251207 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Change of the circadian cycle
Description: Reducing sleep at night for four consecutive days (enabling sleep between 8:00 and 17:00)
Study NCT05251207 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Change of the circadian cycle
Description: Reducing sleep at night for four consecutive days (enabling sleep between 8:00 and 17:00)
Study NCT06676787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transportation Voucher, Comunity engagement and microplannnig support
Description: Transportation vouchers will be provided to caregivers of eligible children after vaccination at designated routine immunisation health facilities. This is in addition to support for microplaning (technical assistance) for these routine immunisation health facilities and comunity engagement at their catchment areas.
Study NCT06676787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Direct Facility Funding, Community Engagement, and Microplaning Support
Description: Direct funding will be provided to designated routine immunisation health facilities monthly, in addition to weekly performance monitoring and quarterly financial capacity building. Also, there will be support for microplaning (technical assistance) for these routine immunisation health facilities and comunity engagement at their catchment areas.
Study NCT06676787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transportation Voucher, Direct Facility Funding, Community engagement and Microplanning support
Description: Transportation vouchers will be provided to caregivers of eligible children after vaccination at designated routine immunisation health facilities. Direct funding will be provided to designated routine immunisation health facilities monthly, in addition to weekly oerformance monitoring and quarterly financial capacity building. Also, there will be support for microplaning (technical assistance) for these routine immunisation health facilities and comunity engagement at their catchment areas.
Study NCT06677125 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrical Mallet
Description: The osteotome will be directly attached and pushed by magnetic mallet and a shock wave will be pushed on their tip. The electrical mallet will be imparted to osteotomes a longitudinal movement along a central axis moving up and down toward pilot bone hole providing a driving mechanism of longitudinal movements. Then the sinus lift instruments (Sweden and Martina) will be used to slowly lift the sinus. After that implant will be placed with the help of implant drilling device.
Study NCT06677125 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Densah bur
Description: The implant motor will be adjusted on reverse-densifying mode with 800 to 1200 rpm. According to the desired implant dimension, it will be started with the smallest densah bur. The first densah bur will advanced in densifying mode with bouncing motion in and out movement with copious irrigation until.
Study NCT04484701 — intervention group
Intervention type: DRUG
Intervention: 68Ga-PSMA-11
Description: PET/CT scan with radiotracer 68Ga-PSMA-11
Study NCT04870645 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Advanced Magnetic Resonance Imaging
Description: Undergo advanced MRI
Study NCT04870645 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional Magnetic Resonance Imaging
Description: Undergo conventional MRI
Study NCT04870645 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadolinium-Chelate
Description: Contrast agent
Study NCT04870645 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iopamidol
Description: Contrast agent
Study NCT06014775 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-CD38 antibody Injection
Description: intravenous Anti-CD38 antibody administration~This study adopts a prospective, single arm, open design method. Ten subjects were enrolled in the study and were treated with Anti-CD38 antibody (16mg/kg/w) for 8 weeks.~The first stage is the main research stage (d1-w8), which is the core treatment period. The subjects will receive intravenous infusion of 16mg/kg Anti-CD38 antibody once a week for 8 weeks to observe the safety and efficacy during treatment.~The second stage (w9-w24) is the stage of withdrawal from the visit, mainly to observe the safety and continuous efficacy of Anti-CD38 antibody after treatment.
Study NCT06139315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 765845
Description: BI 765845
Study NCT06139315 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05913141 — intervention group
Intervention type: OTHER
Intervention: Drug screen with PDO/PDO-TIL/PDOTS
Description: Drug screen with patient-derived organoids, patient-derived organoids-tumor-infiltrating lymphocyte coculture system, or patient-derived organotypic tissue spheroids.
Study NCT05890313 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mini Mental State Examination
Description: MMSE is a clinically validated cognitive test, broadly used in healthcare and scientific settings, and it is administered to individuals with cognitive complaints suspected of cognitive decline whose educational literacy is of three to four years of schooling. It is validated in the general Portuguese population and can discriminate normal cognition from dementia.
Study NCT05890313 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Montreal Cognitive Assessment
Description: MoCA is a clinically validated cognitive test, broadly used in healthcare and scientific settings, and it is administered to individuals with cognitive complaints suspected of cognitive decline whose educational literacy is, at least, of four years of schooling. It is validated in general Portuguese population and can discriminate MCI from dementia.
Study NCT05890313 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brain on Track (version BOT.0.0.0 03.03.2023)
Description: Brain on Track is a class I web-based software medical device, accessible on most platforms, including desktops and laptops. It is designed to allow periodic self-administered cognitive tests to be performed, enabling a cognitive assessment and continuous monitoring of the cognitive state of the patient remotely. It is based on the classic tests of neuropsychological assessment and allows assessing the main areas of cognition through a test lasting approximately 22 minutes. The stimuli that integrate each subtest are randomized between sessions, which reduces the effect of learning and allows the accomplishment of serial assessments.The test is available in three versions, adapted to different levels of schooling: 1-4 years, 5-9 years and 10+ years. The performance in each test is compared with normative population data and performance over time. For each test performed, Brain on Track presents a cumulative risk score for the presence of cognitive impairment.
Study NCT04621006 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Continuously assessment of disease activity
Description: Continuous measures of disease activity and activity in the contact activation system.
Study NCT05739877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-1229_01 2.5/500mg (Before)
Description: single dose administration (one tablet once a day)
Study NCT05739877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-1229_01 2.5/500mg (After)
Description: single dose administration (one tablet once a day)
Study NCT05526859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinsiotaping for wrist flexor muscles
Description: The flexor muscles of the wrist area will be targeted.
Study NCT05526859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping for wrist extensor muscles
Description: The extensor muscles of the wrist area will be targeted.
Study NCT05510778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Charcocaps
Description: 250 mg capsules containing Activated charcoal, Gelatin, Titanium Dioxide, and Carmine
Study NCT05510778 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: capsules containing \~250 mg cellulose
Study NCT04940442 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Outreach
Description: Active: Outreach offering FIT or colonoscopy. Sequential: Outreach offering FIT first, and then offering colonoscopy to those still unscreened
Study NCT06169930 — intervention group
Intervention type: OTHER
Intervention: This was an observational study without any intervention
Description: This was an observational study without any intervention
Study NCT05678075 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Whole-food plant-based nutrition education
Description: Participants will receive an educational intervention regarding the benefits of a whole food plant-based diet and how to incorporate more plant-based foods into their diets. The intervention will last 6 weeks.
Study NCT05319080 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: During the rTMS session, an electromagnetic coil is placed against the subjects scalp on the left side of the head. The electromagnet painlessly delivers a magnetic pulse that stimulates nerve cells in the region of the brain involved in speech perception.
Study NCT04901312 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adolescent Community Reinforcement Approach
Description: The Adolescent Community Reinforcement Approach (A-CRA) is a developmentally-appropriate behavioral treatment for youth and young adults ages 12 to 24 years old with substance use disorders. A-CRA seeks to increase the family, social, and educational/vocational reinforces to support recovery. This intervention has been implemented in outpatient, intensive outpatient, and residential treatment settings. A-CRA includes guidelines for three types of sessions: individuals alone, parents/caregivers alone, and individuals and parents/caregivers together. According to the individual's needs and self-assessment of happiness in multiple life areas, clinicians choose from a variety of A-CRA procedures that address, for example, problem-solving skills to cope with day-to-day stressors, communication skills, and active participation in positive social and recreational activities with the goal of improving life satisfaction and eliminating alcohol and substance use problems.
Study NCT04901312 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assertive Continuing Care
Description: Assertive Continuing Care (ACC) uses Community Reinforcement Approach (CRA) procedures, home visits, and case management for individuals following an initial substance use treatment episode. It stresses rapid initiation of services after discharge from residential, intensive outpatient, or regular outpatient treatment in order to promote recovery and prevent relapse.
Study NCT05975242 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smartphone diabetes management application
Description: The intervention is a smartphone diabetes management application that is combined with structured blood glucose testing.
Study NCT04843488 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Guided bone regeneration with a PTFE membrane
Description: Xenograft bovine spongious bone substitute mixed with autogenous intraorally harvested particulated bone is used and spatially contained with a PTFE membrane secured with Ti pins and screws.
Study NCT04843488 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration with a PTFE+collagen membrane
Description: Xenograft bovine spongious bone substitute mixed with autogenous intraorally harvested particulated bone is used and spatially contained with a PTFE membrane secured with Ti pins and screws and covered with a Collagen membrane subsequently.
Study NCT06032884 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: continuous renal replacement therapy (CRRT)
Description: renal replacement therapy (RRT).
Study NCT06032884 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intermittent hemodialysis (IHD)
Description: renal replacement therapy (RRT).
Study NCT06477627 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: change of environment
Description: The participants will change from inland to coastal environment to see the effect. We will take VAMS blood samples and nose swabs from the participant to measure this effect.
Study NCT06477627 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: no intervention
Description: reference groups, stay in their coastal or inland environment
Study NCT05425160 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive lower limb activities (Chair rise and Step ups)
Description: Progressive lower limb activities (Chair rise and Step ups) were be carried out weekly for upto 6 weeks. Before initiation, cardiopulmonary parameters i.e. Heart rate, oxygen saturation, cardiac output and stroke volume were measured at baseline and later at the termination of activity on each week. Initially, five repeated chair rise were conducted through SPPB and the time was noted to complete the task and step ups through 6MWD for a total period of 30 min. Lastly, fatigue component was assessed via FAS.
Study NCT04901312 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma Affect Regulation Guide for Education and Therapy
Description: Trauma Affect Regulation: Guide for Education and Therapy is a psychosocial intervention for traumatized adolescents, adults, and families, and for workforce and organizational responses to secondary/vicarious traumatization. T4, the 4-session version, provides education about the impact of complex traumatic stress on the brain's stress response system, and strengths-based practical skills for re-setting the trauma-related alarm/survival reactions that occur in complex PTSD.
Study NCT05425160 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard aerobic exercise i.e. low intensity walking
Description: Standard aerobic exercise i.e. low intensity walking were conducted in both the groups. Follow up phone calls and 1 OPD visit were scheduled accordingly
Study NCT04901312 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Motivational interviewing is a collaborative, person-centered form of guiding to elicit and strengthen motivation for change.
Study NCT05883553 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Usability and added value of device within sexual activity
Description: Participants and there partners will be asked to use the device over the course of 4 months, during which both will provide answers to questionnaires on quality of relation and sexual life, and detailed questions on the usability and the added value of the used device during sexual activity along with overall satisfaction with the device.